Effect of apricoxib, a novel COX-2 inhibitor, on the efficacy of standard therapy in human pancreatic cancer cell lines in vitro and in vivo

被引：1
|
作者：
Kirane, A. R. [1 ]
机构：
[1] Univ Texas Southwestern, Dallas, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.227
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
227
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Inhibition of COX-2 with apricoxib enhances the efficacy of standard therapy in preclinical models of human pancreatic cancer
    Kirane, Amanda R.
    [J]. CANCER RESEARCH, 2011, 71
  • [2] Apricoxib, a Novel Inhibitor of COX-2, Markedly Improves Standard Therapy Response in Molecularly Defined Models of Pancreatic Cancer
    Kirane, Amanda
    Toombs, Jason E.
    Ostapoff, Katherine
    Carbon, Juliet G.
    Zaknoen, Sara
    Braunfeld, Jordan
    Schwarz, Roderich E.
    Burrows, Francis J.
    Brekken, Rolf A.
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (18) : 5031 - 5042
  • [3] Apricoxib, a COX-2 inhibitor for the potential treatment of pain and cancer
    Rao, P. N. Praveen
    Grover, Rajesh K.
    [J]. IDRUGS, 2009, 12 (11) : 711 - 722
  • [4] The effect of combined treatment with COX-2 inhibitor and EGFR inhibitor in lung cancer cell lines
    Kim, H. R.
    Kim, N. R.
    Jeong, E. H.
    Lee, T. G.
    Kim, S. Y.
    Kim, C. H.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S612 - S612
  • [5] Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines
    Bocca, Claudia
    Bozzo, Francesca
    Bassignana, Andrea
    Miglietta, Antonella
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2011, 350 (1-2) : 59 - 70
  • [6] Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines
    Claudia Bocca
    Francesca Bozzo
    Andrea Bassignana
    Antonella Miglietta
    [J]. Molecular and Cellular Biochemistry, 2011, 350 : 59 - 70
  • [7] In vitro and in vivo inhibitory effect of three Cox-2 inhibitors and epithelial-to-mesenchymal transition in human bladder cancer cell lines
    Adhim, Z.
    Matsuoka, T.
    Bito, T.
    Shigemura, K.
    Lee, K-M
    Kawabata, M.
    Fujisawa, M.
    Nibu, K.
    Shirakawa, T.
    [J]. BRITISH JOURNAL OF CANCER, 2011, 105 (03) : 393 - 402
  • [8] In vitro and in vivo inhibitory effect of three Cox-2 inhibitors and epithelial-to-mesenchymal transition in human bladder cancer cell lines
    Z Adhim
    T Matsuoka
    T Bito
    K Shigemura
    K-M Lee
    M Kawabata
    M Fujisawa
    K Nibu
    T Shirakawa
    [J]. British Journal of Cancer, 2011, 105 : 393 - 402
  • [9] In vitro cytotoxic evaluation of some synthesized COX-2 inhibitor derivatives against a panel of human cancer cell lines
    Sadeghi-Aliabadi, H.
    Aliasgharluo, M.
    Fattahi, A.
    Mirian, M.
    Ghannadian, M.
    [J]. RESEARCH IN PHARMACEUTICAL SCIENCES, 2013, 8 (04) : 299 - 304
  • [10] Effect of the combination of docetaxel, zoledronic acid, and a COX-2 inhibitor on the growth of human breast cancer cell lines
    Witters, LM
    Crispino, J
    Fraterrigo, T
    Green, J
    Lipton, A
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (04): : S92 - S97
12345